Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Vascular Neurology
•
Invited Professor Series
Is perfusion imaging reliable in determining stroke infarct vs. area at risk?
Answer from: at Community Practice
It has not been studied in ICAD. More studies are needed to help elucidate this.
Sign in or Register to read more
Answer from: at Academic Institution
Yes, I use perfusion. However, I also emphasize on carefully examining the plain CT scan with ASPECTS windows, as it provides more definitive information.
Sign in or Register to read more
16097
20901
Related Questions
When do you consider cardiac CT to evaluate for etiology of acute ischemic stroke?
Would you consider giving thrombolytic therapy for patients with acute vision loss concerning for CRAO based on history and within the window before any ophthalmological assessment and confirmation?
How do you assess periprocedural risk for patients with incidental silent ischemic infarcts scheduled for elective surgeries, major or intravascular procedures?
What is the value of sending placental pathology in neonatal patients who have suffered an in-utero arterial ischemic stroke?
Is there a role for using parenteral anticoagulation for occlusive extensive ICA thrombus with acute onset of symptoms when patients are not candidates for endovascular therapy, such as low NIHSS?
In ischemic stroke patients with low LDL levels (<30-50 mg/dl), would you consider lowering LDL levels to lower values without concern for any side effects?
How do you determine which patients with ICAS are the best candidates for balloon angioplasty versus those who should continue with aggressive medical management alone?
How do you manage patients with atrial fibrillation having a thromboembolic infarct despite being on adequate anticoagulation?
What are your top takeaways from ISC 2025?
Would you recommend dual antiplatelet therapy or anticoagulation for a patient previously on aspirin who has a breakthrough stroke with history of CADASIL?